Abstract

BackgroundDespite the significant contributions of monocytes to HIV persistence, the HIV-monocyte interaction remains elusive. For patients on antiretroviral therapy, previous studies observed a virological suppression rate of >70% and suggested complete viral suppression as the primary goal. Although some studies have reported genetic dysregulations associated with HIV disease progression, research on ex vivo-derived monocytic transcriptomes from HIV+ patients with differential responses to therapy is limited. This study investigated the monocytic transcriptome distinctions between patients with sustained virus suppression and those with virological failure during highly active antiretroviral therapy (HAART).MethodsGenome-wide transcriptomes of primary monocytes from five HIV+ patients on HAART who sustainably controlled HIV to below detection level (BDL), five HIV+ patients on HAART who consecutively experienced viremia, and four healthy HIV sero-negative controls were analyzed using Illumina microarray. Pairwise comparisons were performed to identify differentially expressed genes followed by quantitative PCR validation. Gene set enrichment analysis was used to check the consistency of our dataset with previous studies, as well as to detect the global dysregulations of the biological pathways in monocytes between viremic patients and BDLs.ResultsPairwise comparisons including viremic patients versus controls, BDL versus controls, and viremic patients versus BDLs identified 473, 76, and 59 differentially expressed genes (fold change > 2 and FDR < 0.05), respectively. The reliability of our dataset was confirmed by gene set enrichment analysis showing that 6 out of 10 published gene lists were significantly enriched (FDR < 0.01) in at least one of the three pairwise comparisons. In the comparison of viremic patients versus BDLs, gene set enrichment analysis revealed that the pathways characterizing the primary functions of monocytes including antigen processing and presentation, FcγR mediated phagocytosis, and chemokine signaling were significantly up-regulated in viremic patients.ConclusionsThis study revealed the first transcriptome distinctions in monocytes between viremic patients and BDLs on HAART. Our results reflected the outcome balanced between the subversion of the monocyte transcriptome by HIV and the compensatory effect adapted by host cells. The up-regulation of antigen presentation pathway in viremic patients particularly highlighted the role of the interface between innate and adaptive immunity in HIV disease progression.

Highlights

  • Monocytes, a key cell type in innate and adaptive immunity, have a propensity to differentiate into macrophages or dendritic cells [1,2]

  • Though less permissive to HIV infection than T cells and macrophages [4,5], monocytes could be infected by HIV [6,7] and infectious virus can be isolated from circulating monocytes in untreated patients and highly active antiretroviral therapy (HAART) responders [4,8]

  • Our analysis at the gene set level has shown that in the comparison of VIR versus below detection level (BDL), the pathways characterizing the primary functions of monocytes including antigen processing and presentation, FcγR mediated phagocytosis, and chemokine signaling were significantly up-regulated in the VIR group

Read more

Summary

Introduction

A key cell type in innate and adaptive immunity, have a propensity to differentiate into macrophages or dendritic cells [1,2]. This differentiation ability, along with the activities of antigen presentation, migration, chemotaxis, and phagocytosis [3], enables them to play crucial roles in HIV pathogenesis. Though less permissive to HIV infection than T cells and macrophages [4,5], monocytes could be infected by HIV [6,7] and infectious virus can be isolated from circulating monocytes in untreated patients and highly active antiretroviral therapy (HAART) responders [4,8]. This study investigated the monocytic transcriptome distinctions between patients with sustained virus suppression and those with virological failure during highly active antiretroviral therapy (HAART)

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call